Skip to main content
Global Site Support | Clinical Trial Imaging Assistance | IXICO
Follow us
✕
Company
Mission
About IXICO
IXI™ Platform
The Power of Neuroimaging
Customers
Partnerships
Leadership Team
Advisors
Careers
Recruitment privacy notice
IXI™ Platform
AI-Driven Insights
Platform Features
Platform Evolution
Services
Imaging Biomarker
Radiological reads
Volumetric MRI
PET & SPECT
Advanced MRI
Trial Management
Data Analytics
Post-Marketing Surveillance
Consultancy
Therapeutic Expertise
Alzheimer's Disease (AD)
Huntington's Disease (HD)
Parkinson's Disease (PD)
Multiple Sclerosis (MS)
Other Rare Neurological Diseases
News & Resources
News
Scientific Publications
Webinars
Downloads
Blog
Investors
Share Price
Governance
AIM Rule 26
Our Board
Oversight
Contacts & Advisers
Investor Resources
Company Documents
Financial Calendar
Investor Presentations
Investor Videos
RNS News
Regulatory Email Alert
Shareholder Info
Contact Us
Submit RFP
Contact Us
Global Site Support
\
News & Resources
News & Resources
Sources
News
Scientific Publications
Webinars
Downloads
Blog
Sources
News
Scientific Publications
Webinars
Downloads
Blog
1 Oct 26
webinars
Where Vascular Disease and Alzheimer’s Meet: Shared Pathways to Cognitive Decline
Watch
1 Oct 26
publications
Contrast ratio assessment of the substantia nigra in neuromelanin-sensitive MRI
Read more
1 Oct 26
news
IXICO to present advancements in neuroimaging for Parkinson’s disease
Read more
29 Sep 26
blog
Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials
Read more
13 Jul 26
blog
White Matter Hyperintensities: A precision neurology tool
Read more
8 Jun 26
news
IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE
Read more
4 Jun 26
blog
Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease
Read more
1 Jun 26
webinars
Understanding Imaging in Parkinson’s Disease Trials: From Eligibility to Efficacy
Watch
19 May 26
news
IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates
Read more
19 May 26
news
Interim results for six months ending 31 March 2026. Continued strong revenue and order book growth.
Read more
12 May 26
news
IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM
Read more
20 Apr 26
blog
From Information to Intelligence: New Platform Identity Explained
Read more
1
2
3
4
5
...
13
Prev
Next
1 - 12 of 150 results
Ixico News on Proactive
IXICO targets growth with AI-powered neuroscience - One2One Investor Forum
October 2nd 2026 07:27 AM
MARKETS LIVE: Wall Street closes mostly higher after sharp rise in Treasury yields
October 1st 2026 20:15 PM
IXICO presents Parkinson's research showing improved brain imaging contrast
October 1st 2026 07:15 AM
IXICO guidance unchanged after Huntington's cancellations
July 13th 2026 06:37 AM
IXICO lifts revenue forecast on contract wins and wider client base - UPDATE
July 7th 2026 09:10 AM
IXICO strengthens Alzheimer's and Parkinson's advisory board with world-class experts
June 8th 2026 13:55 PM
IXICO expands scientific network in Alzheimer’s and Parkinson’s disease
June 8th 2026 06:26 AM
Bram Goorden discusses IXICO growth plans - ICYMI
May 24th 2026 06:50 AM
IXICO contract wins provide near-total revenue visibility for current year
May 21st 2026 10:45 AM
IXICO, Ilika, EMV Capital, Zephyr Energy, Metals One, Bradda Head Lithium - Small Cap Snapshot
May 21st 2026 08:25 AM
IXICO wins £1.3 million in Alzheimer's and Huntington's contracts
May 21st 2026 06:21 AM
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
May 19th 2026 10:00 AM
IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates
May 19th 2026 06:15 AM
IXICO targets 15% revenue growth as order book swells and strategy takes shape
May 19th 2026 06:11 AM
IXICO launches latest version of AI neuroimaging platform
May 12th 2026 06:21 AM
Updated: 7 minute 58 seconds ago
Sign-up to the latest from IXICO